Literature DB >> 16700563

Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.

Ayyalusamy Ramamoorthy1, Sathiah Thennarasu, Anmin Tan, Kiran Gottipati, Sreeja Sreekumar, Deborah L Heyl, Florence Y P An, Charles E Shelburne.   

Abstract

Tachyplesin I is a cyclic beta-sheet antimicrobial peptide isolated from the hemocytes of Tachypleus tridentatus. The four cysteine residues in tachyplesin I play a structural role in imparting amphipathicity to the peptide which has been shown to be essential for its activity. We investigated the role of amphipathicity using an analogue of tachyplesin I (TP-I), CDT (KWFRVYRGIYRRR-NH(2)), in which all four cysteines were deleted. Like TP-I, CDT shows antimicrobial activity and disrupts Escherichia coli outer membrane and model membranes mimicking bacterial inner membranes at micromolar concentrations. The CDT peptide does not cause hemolysis up to 200 microg/mL while TP-I showed about 10% hemolysis at 100 microg/mL and about 25% hemolysis at 150 microg/mL. Peptide-into-lipid titrations under isothermal conditions reveal that the interaction of CDT with lipid membranes is an enthalpy-driven process. Binding assays performed using fluorometry demonstrate that the peptide CDT binds and inserts into only negatively charged membranes. The peptide-induced thermotropic phase transition of MLVs formed of DMPC and the DMPC/DMPG (7:3) mixture suggests specific lipid-peptide interactions. The circular dichroism study shows that the peptide exists as an unordered structure in an aqueous buffer and adopts a more ordered beta-structure upon binding to negatively charged membrane. The NMR data suggest that CDT binding to negatively charged bilayers induces a change in the lipid headgroup conformation with the lipid headgroup moving out of the bilayer surface toward the water phase, and therefore, a barrel stave mechanism of membrane disruption is unlikely as the peptide is located near the headgroup region of lipids. The lamellar phase (31)P chemical shift spectra observed at various concentrations of the peptide in bilayers suggest that the peptide may function neither via fragmentation of bilayers nor by promoting nonlamellar structures. NMR and fluorescence data suggest that the presence of cholesterol inhibits the peptide binding to the bilayers. These properties help to explain that cysteine residues may not contribute to antimicrobial activity and that the loss of hemolytic activity is due to lack of hydrophobicity and amphipathicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700563      PMCID: PMC2515376          DOI: 10.1021/bi052629q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  63 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices.

Authors:  N G Park; S Lee; O Oishi; H Aoyagi; S Iwanaga; S Yamashita; M Ohno
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

3.  Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog.

Authors:  K Matsuzaki; S Yoneyama; N Fujii; K Miyajima; K Yamada; Y Kirino; K Anzai
Journal:  Biochemistry       Date:  1997-08-12       Impact factor: 3.162

4.  Antimicrobial activity and conformation of tachyplesin I and its analogs.

Authors:  H Tamamura; R Ikoma; M Niwa; S Funakoshi; T Murakami; N Fujii
Journal:  Chem Pharm Bull (Tokyo)       Date:  1993-05       Impact factor: 1.645

5.  Effects of cholesterol on the properties of equimolar mixtures of synthetic phosphatidylethanolamine and phosphatidylcholine. A 31P NMR and differential scanning calorimetry study.

Authors:  P R Cullis; P W van Dijck; B de Kruijff; J de Gier
Journal:  Biochim Biophys Acta       Date:  1978-10-19

6.  Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes.

Authors:  J Hong; Z Oren; Y Shai
Journal:  Biochemistry       Date:  1999-12-21       Impact factor: 3.162

7.  MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain.

Authors:  Kevin J Hallock; Dong-Kuk Lee; A Ramamoorthy
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

8.  Peptide-induced formation of cholesterol-rich domains.

Authors:  Richard M Epand; Brian G Sayer; Raquel F Epand
Journal:  Biochemistry       Date:  2003-12-16       Impact factor: 3.162

9.  Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes.

Authors:  G Beschiaschvili; J Seelig
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

10.  Interaction of E2 and NS3 synthetic peptides of GB virus C/hepatitis G virus with model lipid membranes.

Authors:  Núria Rojo; María J Gómara; María A Busquets; María A Alsina; Isabel Haro
Journal:  Talanta       Date:  2003-06-13       Impact factor: 6.057

View more
  25 in total

1.  Sensitivity and resolution enhancement in solid-state NMR spectroscopy of bicelles.

Authors:  Sergey V Dvinskikh; Kazutoshi Yamamoto; Ulrich H N Dürr; Ayyalusamy Ramamoorthy
Journal:  J Magn Reson       Date:  2006-11-02       Impact factor: 2.229

Review 2.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

3.  A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.

Authors:  Falk Duchardt; Ivo R Ruttekolk; Wouter P R Verdurmen; Hugues Lortat-Jacob; Jochen Bürck; Hansjörg Hufnagel; Rainer Fischer; Maaike van den Heuvel; Dennis W P M Löwik; Geerten W Vuister; Anne Ulrich; Michel de Waard; Roland Brock
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

4.  Accelerated molecular dynamics simulation analysis of MSI-594 in a lipid bilayer.

Authors:  Shruti Mukherjee; Rajiv K Kar; Ravi Prakash Reddy Nanga; Kamal H Mroue; Ayyalusamy Ramamoorthy; Anirban Bhunia
Journal:  Phys Chem Chem Phys       Date:  2017-07-26       Impact factor: 3.676

5.  Implicit Membrane Investigation of the Stability of Antimicrobial Peptide β-Barrels and Arcs.

Authors:  Richard B Lipkin; Themis Lazaridis
Journal:  J Membr Biol       Date:  2014-11-28       Impact factor: 1.843

6.  Hairpin structure stability plays a role in the activity of two antimicrobial peptides.

Authors:  Kalkena Sivanesam; Brandon L Kier; Samuel D Whedon; Champak Chatterjee; Niels H Andersen
Journal:  FEBS Lett       Date:  2016-11-21       Impact factor: 4.124

7.  Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity.

Authors:  Allison A Langham; Himanshu Khandelia; Benjamin Schuster; Alan J Waring; Robert I Lehrer; Yiannis N Kaznessis
Journal:  Peptides       Date:  2008-03-28       Impact factor: 3.750

8.  NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization.

Authors:  Anirban Bhunia; Prerna N Domadia; Jaume Torres; Kevin J Hallock; Ayyalusamy Ramamoorthy; Surajit Bhattacharjya
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Determining the mode of action involved in the antimicrobial activity of synthetic peptides: a solid-state NMR and FTIR study.

Authors:  Aurélien Lorin; Mathieu Noël; Marie-Ève Provencher; Vanessa Turcotte; Sébastien Cardinal; Patrick Lagüe; Normand Voyer; Michèle Auger
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

10.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.